TY - JOUR T1 - Prevalence and Nature of Sexual Violence in Older Adults in Europe: A Critical Interpretive Synthesis of Evidence JF - medRxiv DO - 10.1101/2020.04.24.20077990 SP - 2020.04.24.20077990 AU - Anne Nobels AU - Christophe Vandeviver AU - Marie Beaulieu AU - Adina Cismaru Inescu AU - Laurent Nisen AU - Nele Van Den Noortgate AU - Tom Vander Beken AU - Gilbert Lemmens AU - Ines Keygnaert Y1 - 2020/01/01 UR - http://medrxiv.org/content/early/2020/04/29/2020.04.24.20077990.abstract N2 - Sexual violence (SV) is an important public health issue with a potential major impact on victims and their peers, offspring and community. However, SV in older adults is under-researched. This paper aims to establish the prevalence and nature of SV in older adults in Europe, link this with existing policies and health care workers’ response to sexual health needs in older age and critically revise the current used frameworks in public health research.We applied a Critical Interpretative Synthesis. After the first phase of purposive sampling we included 14 references. Another 14 references were included after the second phase of theoretical sampling. We ultimately included 16 peer-reviewed articles and 12 documents from the grey literature.0.0% to 3.1% of older adults in Europe were sexually victimised in the past year. Lifetime prevalence of SV was 6.3%. Information on specific risk factors and assailants committing SV in old age is non- existing. Although in theory policy makers increasingly recognise the importance of sexual health in older age, SV in older adults is not mentioned in policy documents on sexual and reproductive health and rights and ageing. In clinical practice, the sexual health needs of older adults remain often unmet. Knowledge about SV in older adults is still limited. Ongoing research does not fully grasp the complexity of SV in older adults. Greater awareness about this topic could contribute to a revision of current policies and health care practices, leading to more tailored care for older victims of SV.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis research was funded by the Belgian Federal Science Policy Belgian Research Action through the Interdisciplinary Networks funding scheme, grant number BR/175/A5/UN-MENAMAIS.Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThere was no dataset used in this manuscript ER -